Ovid Therapeutics Inc.
General ticker "OVID" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $33.7M (TTM average)
Ovid Therapeutics Inc. follows the US Stock Market performance with the rate: 47.9%.
Estimated limits based on current volatility of 6.1%: low 1.55$, high 1.75$
Factors to consider:
- Total employees count: 23 (-42.5%) as of 2024
- Top business risk factors: Insufficient funding, Profitability concerns, Drug development risks, Economic downturns and volatility, Regulatory and compliance
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [0.57$, 1.59$]
- 2025-12-31 to 2026-12-31 estimated range: [0.67$, 1.76$]
Financial Metrics affecting the OVID estimates:
- Positive: with PPE of -2.6 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -80.67 <= 0.33
- Positive: Shareholder equity ratio, % of 74.02 > 63.39
- Negative: negative Net income
- Positive: Investing cash flow per share per price, % of 78.71 > -0.66
- Positive: Interest expense per share per price, % of 0 <= 0.01
Short-term OVID quotes
Long-term OVID plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $1.50MM | $0.39MM | $0.57MM |
| Operating Expenses | $57.05MM | $59.67MM | $62.45MM |
| Operating Income | $-55.55MM | $-59.28MM | $-61.88MM |
| Non-Operating Income | $1.38MM | $6.94MM | $35.45MM |
| R&D Expense | $24.62MM | $28.59MM | $36.77MM |
| Income(Loss) | $-54.17MM | $-52.34MM | $-26.43MM |
| Profit(Loss)* | $-54.17MM | $-52.34MM | $-26.43MM |
| Stockholders Equity | $132.27MM | $87.80MM | $68.23MM |
| Assets | $155.27MM | $144.03MM | $92.17MM |
| Operating Cash Flow | $-55.23MM | $-45.78MM | $-55.96MM |
| Capital expenditure | $1.42MM | $0.14MM | $0.07MM |
| Investing Cash Flow | $-87.88MM | $-2.58MM | $54.59MM |
| Financing Cash Flow | $0.18MM | $30.54MM | $0.62MM |
| Earnings Per Share** | $-0.77 | $-0.74 | $-0.37 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.